期刊文献+

丹皮酚对溃疡性结肠炎小鼠的治疗作用及机制 被引量:1

Effect and mechanism of paeonol on ulcerative colitis in mice
原文传递
导出
摘要 目的探究丹皮酚对溃疡性结肠炎小鼠结肠损伤的保护作用及可能机制。方法C57BL/6小鼠40只,随机分为对照组、溃疡性结肠炎组、丹皮酚低剂量组和丹皮酚高剂量组,每组10只。测量结肠长度并计算疾病活动指数评分;HE染色观察结肠组织形态学变化;ELISA方法检测结肠组织炎症因子水平及环腺苷酸(Cyclic adenosine monophosphate,cAMP)含量;TUNEL方法检测结肠组织细胞凋亡;Western blot检测磷酸二酯酶4(phosphodiesterase 4,PDE4)和蛋白激酶A(protein kinase A,PKA)蛋白表达。结果丹皮酚抑制溃疡性结肠炎小鼠结肠缩短,降低小鼠疾病活动指数评分,改善结肠组织形态,降低结肠组织细胞凋亡,抑制结肠组织炎症因子水平,降低结肠组织PDE4蛋白表达水平,增加结肠组织cAMP含量和PKA蛋白表达水平。结论丹皮酚减轻溃疡性结肠炎小鼠结肠损伤,其作用机制可能与调控PDE4/cAMP/PKA通路有关。 Objective To explore the protective effect of paeonol on colonic injury in mice with ulcerative colitis and its possible mechanism.Methods Forty C57 BL/6 mice were randomly divided into control group,ulcerative colitis group,paeonol low-dose group and paeonol high-dose group,with 10 mice in each group.Colon length was measured and disease activity index scores were calculated.HE staining was used to observe the histological changes of colon.The levels of inflammatory factors and Cyclic adenosine monophosphate(cAMP)in colon tissue were detected by ELISA.TUNEL assay was used to detect cell apoptosis in colon tissue.Western blot was used to detect the expression of phosphodiesterase 4(PDE4)and protein kinase A(PKA).Results Paeonol inhibited colon shortening in mice with ulcerative colitis,decreased the score of disease activity index,improved the morphology of colon tissue,decreased the apoptosis of colon tissue cells,inhibited the level of inflammatory factors in colon tissue,decreased the expression of PDE4 in colon tissue,increased the content of cAMP and the expression of PKA protein in colon tissue.Conclusion Paeonol alleviates colon injury in mice with ulcerative colitis,and the mechanism may be related to the PDE4/cAMP/PKA pathway.
作者 曹男 马智 李昶 林连捷 CAO Nan;MA Zhi;LI Chang;LIN Lian-jie(The Second Department of Gastroenterology,Liaoning Provincial People’s Hospital,Shenyang 110016,China)
出处 《解剖科学进展》 CAS 2022年第1期1-4,8,共5页 Progress of Anatomical Sciences
基金 辽宁省自然科学基金(2014021083)。
关键词 丹皮酚 溃疡性结肠炎 磷酸二酯酶4 环腺苷酸 蛋白激酶A Paeonol ulcerative colitis PDE4 cAMP PKA
  • 相关文献

参考文献3

二级参考文献14

  • 1Kavitha Subramaniam,James D’Rozario,Paul Pavli.Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review[J]. J Gastroenterol Hepatol . 2012 (1)
  • 2Mehmet Coskun,Mohammad Salem,Jannie Pedersen,Ole Haagen Nielsen.Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease[J].Pharmacological Research.2013
  • 3William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar J?rnerot,Paul Rutgeerts.Subcutaneous Golimumab Maintains Clinical Response in Patients with Moderate-To-Severe Ulcerative Colitis[J].Gastroenterology.2013
  • 4William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar J?rnerot,Toshifumi Hibi,Paul Rutgeerts.Subcutaneous Golimumab Induces Clinical Response and Remission in Patients with Moderate-To-Severe Ulcerative Colitis[J].Gastroenterology.2013
  • 5David Laharie,Arnaud Bourreille,Julien Branche,Matthieu Allez,Yoram Bouhnik,Jerome Filippi,Frank Zerbib,Guillaume Savoye,Maria Nachury,Jacques Moreau,Jean-Charles Delchier,Jacques Cosnes,Elena Ricart,Olivier Dewit,Antonio Lopez-Sanroman,Jean-Louis Dupas,Franck Carbonnel,Gilles Bommelaer,Benoit Coffin,Xavier Roblin,Gert Van Assche,Maria Esteve,Martti F?rkkil?,Javier P Gisbert,Philippe Marteau,Stephane Nahon,Martine de Vos,Denis Franchimont,Jean-Yves Mary,Jean-Frederic Colombel,Marc Lémann.Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial[J].The Lancet.2012(9857)
  • 6Hideyuki Yoshida,Akihiro Kimura,Tomohiro Fukaya,Takashi Sekiya,Rimpei Morita,Takashi Shichita,Hiromasa Inoue,Akihiko Yoshimura.Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation[J].Biochemical and Biophysical Research Communications.2012(2)
  • 7Hiu Kiu,Sandra E. Nicholson.Biology and significance of the JAK/STAT signalling pathways[J].Growth Factors.2012(2)
  • 8Eric R. Fedyk,Tim Wyant,Li‐Li Yang,Vilmos Csizmadia,Kristine Burke,Hua Yang,Vivek J. Kadambi.Exclusive antagonism of the α<sub>4</sub>β<sub>7</sub> integrin by vedolizumab confirms the gut‐selectivity of this pathway in primates[J].Inflamm Bowel Dis.2012(11)
  • 9William J. Sandborn,Gert van Assche,Walter Reinisch,Jean–Frederic Colombel,Geert D’Haens,Douglas C. Wolf,Martina Kron,Mary Beth Tighe,Andreas Lazar,Roopal B. Thakkar.Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis[J].Gastroenterology.2012(2)
  • 10O. H. Nielsen,J. B. Seidelin,L. K. Munck,G. Rogler.Use of biological molecules in the treatment of inflammatory bowel disease[J].Journal of Internal Medicine.2011(1)

共引文献53

同被引文献13

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部